 |
PDBsum entry 1fhc
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
C-terminal domains of factor h
|
PDB id
|
|
|
|
1fhc
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Complement c3b/c3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-Terminal domain of complement factor h.
|
 |
|
Authors
|
 |
J.Hellwage,
T.S.Jokiranta,
M.A.Friese,
T.U.Wolk,
E.Kampen,
P.F.Zipfel,
S.Meri.
|
 |
|
Ref.
|
 |
J Immunol, 2002,
169,
6935-6944.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Factor H (FH) is a potent suppressor of the alternative pathway of C in plasma
and when bound to sialic acid- or glycosaminoglycan-rich surfaces. Of the three
interaction sites on FH for C3b, one interacts with the C3d part of C3b. In this
study, we generated recombinant constructs of FH and FH-related proteins (FHR)
to define the sites required for binding to C3d. In FH, the C3d-binding site was
localized by surface plasmon resonance analysis to the most C-terminal short
consensus repeat domain (SCR) 20. To identify amino acids of FH involved in
binding to C3d and heparin, we compared the sequences of FH and FHRs and
constructed a homology-based molecular model of SCR19-20 of FH. Subsequently, we
created an SCR15-20 mutant with substitutions in five amino acids that were
predicted to be involved in the binding interactions. These mutations reduced
binding of the SCR15-20 construct to both C3b/C3d and heparin. Binding of the
wild-type SCR15-20, but not the residual binding of the mutated SCR15-20, to C3d
was inhibited by heparin. This indicates that the heparin- and C3d-binding sites
are overlapping. Our results suggest that a region in the most C-terminal domain
of FH is involved in target recognition by binding to C3b and surface
polyanions. Mutations in this region, as recently reported in patients with
familial hemolytic uremic syndrome, may lead to indiscriminatory C attack
against self cells.
|
 |
|
Secondary reference #1
|
 |
|
Title
|
 |
X-Ray crystal structure of c3d: a c3 fragment and ligand for complement receptor 2.
|
 |
|
Authors
|
 |
B.Nagar,
R.G.Jones,
R.J.Diefenbach,
D.E.Isenman,
J.M.Rini.
|
 |
|
Ref.
|
 |
Science, 1998,
280,
1277-1281.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
 |
 |
|
 |
|
 |
Figure 2.
Fig. 2. Sequence conservation of C3d. (A) Multiple sequence
alignment of selected species of C3d and human C4d (B isotype)
(21). Residues shaded in yellow are at least 90% buried in the^
C3d structure, and those shaded in red are residues composing
the contiguous surface patch labeled in (B). Numbers correspond^
to the degree of conservation in C3d sequences only: 0 (not
conserved) to A (highly conserved), as determined by the program
AMAS (32). In human C4d, approximately 75% of the core residues,
as well as the putative domain interface residues, are highly
conserved^ [a conservation index (cons. index) of 7 or higher
when included^ in the AMAS calculation], which suggests that it
will adopt a^ similar fold and possess the analogous domain
interface. The helical segments in human C3d are indicated by
blue cylinders. [The figure^ was prepared with ALSCRIPT (35).]
(B) Mapping of residue^ conservation as determined in (A) onto
the surface of C3d; white^ (not conserved) to progressively
darker red (highly conserved). [The figure was prepared with
GRASP (36).] The conserved patch includes most of the surface
apolar residues shown in Fig. 1C.
|
 |
Figure 3.
Fig. 3. Stereo view of an electrostatic surface rendition of
C3d, showing the acidic pocket on the concave end of the
molecule. Acidic^ and basic residues are colored red and blue,
respectively. Labeled^ are the surface-exposed residues that
form the pocket. The contour level is at ±10 kT.
|
 |
|
 |
 |
|
The above figures are
reproduced from the cited reference
with permission from the AAAs
|
 |
|
Secondary reference #2
|
 |
|
Title
|
 |
Solution structure of a pair of complement modules by nuclear magnetic resonance.
|
 |
|
Authors
|
 |
P.N.Barlow,
A.Steinkasserer,
D.G.Norman,
B.Kieffer,
A.P.Wiles,
R.B.Sim,
I.D.Campbell.
|
 |
|
Ref.
|
 |
J Mol Biol, 1993,
232,
268-284.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
|
|
|
|
 |